AI Verdict
RLYB has stronger fundamentals based on our AI analysis.
RLYB vs RLMD Fundamental Comparison
| Metric | RLYB | RLMD |
|---|---|---|
| Revenue | $858,000.0 | $5.2M |
| Net Income | $-9.0M | $-57.4M |
| Net Margin | -1,046.4% | -1,113.9% |
| ROE | -15.5% | -66.3% |
| ROA | -14.4% | -61.0% |
| Current Ratio | 14.50x | 14.62x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-1.59 | $-1.45 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RLYB vs RLMD: Frequently Asked Questions
Is RLYB or RLMD a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RLYB has stronger fundamentals. RLYB is rated SELL (72% confidence) while RLMD is rated STRONG SELL (78% confidence). This is not investment advice.
How does RLYB compare to RLMD fundamentally?
Rallybio Corp has ROE of -15.5% vs RELMADA THERAPEUTICS, INC.'s -66.3%. Net margins are -1,046.4% vs -1,113.9% respectively.
Which stock pays higher dividends, RLYB or RLMD?
RLYB has a dividend yield of N/A or no dividend while RLMD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RLYB or RLMD for long term?
For long-term investing, consider that RLYB has SELL rating with 72% confidence, while RLMD has STRONG SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RLYB vs RLMD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RLYB vs RLMD, the AI consensus favors RLYB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.